LDL-IN-3

• UNSPSC Description:

  LDL-IN-3 is an anti-atherosclerotic compound extracted from patent WO/2005/039596A1, example C25 and patent US 6133467, example 3.

• Target Antigen:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Metabolism-sugar/lipid metabolism

• Field of Research:

  Metabolic Disease; Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/2,6-Bis_1,1-dimethylethyl_-4-[[_4-methoxyphenyl_dimethylsilyl]methoxy]phenol.html

• Solubility:

  10 mM in DMSO

• Smiles:

  OC1=C(C(C)(C)C)C=C(OC[Si](C)(C2=CC=C(OC)C=C2)C)C=C1C(C)(C)C

• Molecular Weight:

  400.63

• References & Citations:

  [1]WO/2005/039596A1|[2]US 6133467

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  180908-67-2